BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 16567676)

  • 1. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
    J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
    Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of expandable electrodes in percutaneous radiofrequency ablation of renal cell carcinoma.
    Gulesserian T; Mahnken AH; Schernthaner R; Memarsadeghi M; Weber M; Tacke A; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):133-9. PubMed ID: 16837160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
    Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
    Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.
    Cho YK; Rhim H; Ahn YS; Kim MY; Lim HK
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S269-74. PubMed ID: 16632687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
    Herrera LJ; Fernando HC; Perry Y; Gooding WE; Buenaventura PO; Christie NA; Luketich JD
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):929-37. PubMed ID: 12698158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience.
    Kariniemi J; Ojala R; Hellström P; Sequeiros RB
    Acta Radiol; 2010 May; 51(4):467-72. PubMed ID: 20380606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
    Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
    Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
    Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
    Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.